Allan Hildesheim mainly investigates Immunology, Cervical cancer, Internal medicine, Cancer and Gynecology. His research in Immunology intersects with topics in Papillomavirus Vaccines and Virology. He combines subjects such as Viral disease, Natural history study and Mass screening with his study of Cervical cancer.
His Internal medicine study frequently links to adjacent areas such as Oncology. His research in the fields of Squamous intraepithelial lesion overlaps with other disciplines such as Triage. His Gynecology research integrates issues from Cervix, Cervicography, Obstetrics, HPV infection and Risk factor.
Immunology, Internal medicine, Cancer, Cervical cancer and Gynecology are his primary areas of study. He works mostly in the field of Immunology, limiting it down to topics relating to Virology and, in certain cases, Papillomavirus Vaccines. Allan Hildesheim works mostly in the field of Internal medicine, limiting it down to concerns involving Oncology and, occasionally, Prospective cohort study.
His work in Cancer addresses subjects such as Epidemiology, which are connected to disciplines such as Young adult. His Cervical cancer research includes themes of Viral disease, Human papillomavirus and Cervix. His Gynecology research incorporates elements of Colposcopy, Obstetrics, HPV infection, Cohort and Risk factor.
His primary scientific interests are in Internal medicine, Immunology, Cancer, Confidence interval and Odds ratio. His studies in Internal medicine integrate themes in fields like Gastroenterology and Oncology. His Immunology study frequently draws connections between related disciplines such as Allele.
His Cancer research includes elements of Public health interventions and Dysplasia. In his study, Insulin is strongly linked to Case-control study, which falls under the umbrella field of Odds ratio. His work carried out in the field of Vaccination brings together such families of science as Randomized controlled trial, Cervical intraepithelial neoplasia, HPV infection and Cervix.
Allan Hildesheim spends much of his time researching Internal medicine, Vaccine trial, Vaccination, Vaccine efficacy and Confidence interval. His studies deal with areas such as Sex organ and Oncology as well as Internal medicine. His work deals with themes such as Randomized controlled trial and HPV infection, which intersect with Vaccination.
His Vaccine efficacy research is multidisciplinary, incorporating elements of Genotype and Human papillomavirus. His study looks at the relationship between Serology and topics such as Real-time polymerase chain reaction, which overlap with Immunology. His Immunology research includes themes of Linkage disequilibrium and Allele.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000
Sophia S. Wang;Mark E. Sherman;Allan Hildesheim;James V. Lacey.
MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins
Srikumar Sengupta;Johan A. den Boon;I-How Chen;Michael A. Newton.
Proceedings of the National Academy of Sciences of the United States of America (2008)
Host and viral genetics and risk of cervical cancer: a review.
Allan Hildesheim;Sophia S Wang.
Virus Research (2002)
Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica.
Rolando Herrero;Wim Quint;Allan Hildesheim;Paula Gonzalez.
PLOS ONE (2013)
An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results.
John T. Schiller;Xavier Castellsagué;Luisa L. Villa;Allan Hildesheim.
Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine
Aimée R. Kreimer;Ana Cecilia Rodriguez;Allan Hildesheim;Rolando Herrero.
Journal of the National Cancer Institute (2011)
A Prospective Study of Human Papillomavirus (HPV) Type 16 DNA Detection by Polymerase Chain Reaction and Its Association with Acquisition and Persistence of Other HPV Types
Kai Li Liaw;Allan Hildesheim;Robert D. Burk;Patti Gravitt.
The Journal of Infectious Diseases (2001)
Re: Specific Antibody Levels at the Cervix During the Menstrual Cycle of Women Vaccinated With Human Papillomavirus 16 Virus-Like Particles
Denise Nardelli-Haefliger;Daniel Wirthner;John T. Schiller;Douglas R. Lowy.
Journal of the National Cancer Institute (2004)
Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon.
Heidi M. Bauer;Allan Hildesheim;Mark H. Schiffman;Andrew G. Glass.
Sexually Transmitted Diseases (1993)
Utility of liquid-based cytology for cervical carcinoma screening: results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma.
Martha L. Hutchinson;David J. Zahniser;Mark E. Sherman;Rolando Herrero.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: